Quick Takeaways
- BridgeBio Pharma LLC has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $156,363,757.
- Recent insider filing activity is available below.
- Info
- Significant Ownership
- Insider Ownership
Insider Trading & Ownership of BridgeBio Pharma LLC
- Location
- Palo Alto, CA
- Summary
- The estimated value of insider holdings of BridgeBio Pharma LLC is at least $156,363,757 dollars as of 16 Oct 2025. BridgeBio Pharma LLC is the 10%+ Owner of BridgeBio Oncology Therapeutics, Inc. and owns shares of BridgeBio Oncology Therapeutics, Inc. (BBOT) stock worth about $156.36M.
- Signature
- /s/ Neil Kumar, Chief Executive Officer of BridgeBio Pharma LLC
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow BridgeBio Pharma LLC and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: BridgeBio Oncology Therapeutics, Inc. ($156,363,757).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of BridgeBio Pharma LLC
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 10%+ Owner | $156,363,757 | 10 Oct 2025 |
Insider Transactions Reported by BridgeBio Pharma LLC:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.